Anti-MMP9 antibody [MMP9/2025R]
Be the first to review this product! Submit a review
|
(6 Publications)
Rabbit Monoclonal MMP9 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 6 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human MMP9.
View Alternative Names
CLG4B, MMP9, Matrix metalloproteinase-9, MMP-9, 92 kDa gelatinase, 92 kDa type IV collagenase, Gelatinase B, GELB
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MMP9 antibody [MMP9/2025R] (AB236494)
Formalin-fixed paraffin-embedded human spleen tissue stained for MMP9 using ab236494 at 1 μg/ml in immunohistochemical analysis.
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Matrix metalloproteinase-9 profoundly influences tissue remodeling inflammation and angiogenesis. It does not form part of a larger protein complex but interacts closely with substrates in the extracellular matrix. MMP-9 plays important roles in processes such as embryogenesis reproduction and wound healing through the remodeling of surrounding tissues. The MMP-9 protein is often measured using assays like ELISA or analyzed via techniques such as Western blotting to determine its expression levels and activity in different biological contexts.
Pathways
MMP-9 participates in the matrix metalloproteinase pathway and the NF-kB signaling pathway. These pathways are essential in orchestrating processes such as tissue remodeling and inflammatory responses. MMP-9 acts alongside other matrix metalloproteinases including MMP-2 and is regulated by factors like cytokines growth factors and hormones ensuring the precision of extracellular matrix degradation during physiological processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Journal of nanobiotechnology 22:251 PubMed38750597
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation research 15:1921-1933 PubMed35321320
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 25:7190-7203 PubMed34169637
2021
Applications
Unspecified application
Species
Unspecified reactive species
Brain pathology (Zurich, Switzerland) 31:e12947 PubMed33694259
2021
Applications
Unspecified application
Species
Unspecified reactive species
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 49:725-731 PubMed33448175
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 10:571181 PubMed33178600
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com